0001225208-22-002833.txt : 20220218 0001225208-22-002833.hdr.sgml : 20220218 20220218211647 ACCESSION NUMBER: 0001225208-22-002833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220216 FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deal Stanley A CENTRAL INDEX KEY: 0001690924 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00442 FILM NUMBER: 22654676 MAIL ADDRESS: STREET 1: C/O THE BOEING COMPANY STREET 2: 100 RIVERSIDE PLAZA, MC 5003-1001 CITY: CHICAGO STATE: IL ZIP: 60606-1596 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOEING CO CENTRAL INDEX KEY: 0000012927 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] IRS NUMBER: 910425694 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P O BOX 3707 MS 1F 31 CITY: SEATTLE STATE: WA ZIP: 98124 BUSINESS PHONE: 312-544-2000 MAIL ADDRESS: STREET 1: 100 N RIVERSIDE PLZ CITY: CHICAGO STATE: IL ZIP: 60606-1596 FORMER COMPANY: FORMER CONFORMED NAME: BOEING AIRPLANE CO DATE OF NAME CHANGE: 19730725 4 1 doc4.xml X0306 4 2022-02-16 0000012927 BOEING CO BA 0001690924 Deal Stanley A 100 N. RIVERSIDE PLAZA M/C 5003-1001 CHICAGO IL 60606 1 EVP, Pres. & CEO, BCA Common Stock 2022-02-16 4 A 0 12874.7470 0.0000 A 60679.2770 D Common Stock 990.1400 I 401(k) plan Common Stock 4319.5800 I Career Shares Stock Option (Right to Buy) 260.9800 2022-02-16 4 A 0 33718.0000 0.0000 A 2025-02-16 2032-02-16 Common Stock 33718.0000 33718.0000 D Represents restricted stock units that will vest and settle in shares of the Company's common stock on a one-for-one basis on February 17, 2025. Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(k) plan. Ownership in the issuer's 401(k) plan is represented by units in the issuer's common stock fund in the plan rather than shares of common stock. The exercise price is equal to 120% of the average of the high and the low trading prices on the date of the grant (the "Grant Date FMV"). The exercise price will be reduced to 110% of the Grant Date FMV if the issuer's total shareholder return ("TSR") over the three-year vesting period exceeds the median TSR for the peer group of companies listed in the award agreement. The option becomes vested and exercisable in full on February 16, 2025, which is the third anniversary of the date of grant. /s/ Dana Kumar, Attorney-in-Fact 2022-02-18